Business

Covid-19: India frees export of anti-malarial drug Hydroxychloroquine

India on Thursday lifted the restriction on the export of anti-malarial drug Hydroxychloroquine, which is widely used around the world as a prophylactic to fight Covid-19.

migrator

New Delhi

In March, the Centre had imposed curbs on the export of Hydroxychloroquine and formulations used to manufacture the medicine.

According to a late night notification by the Ministry of Commerce and Industry, the export status of the medication and the composition ingredients have been changed from "prohibited" to "free".

The notification was issued by the Directorate General of Foreign Trade (DGFT).

India is a major exporter of Hydroxychloroquine, which has witnessed a surge in demand amid the novel coronavirus crisis.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Also Read

Digital route overtakes cash in Tamil Nadu bribe deals, DVAC data shows

‘Gold is Radha’s weakness’: Ambika refutes Rs 46 crore cheque fraud allegations

How Chennai police tried to drop Pocso case against mining baron Veeramani in February

IIT Bombay alumni seek fair probe into student's suicide, appeal against 'media trial'

US announces USD 31 million support for flood-hit Nepal

SCROLL FOR NEXT